Showing results (371-380 of 463) with videos related to

Sort By:
Pageof 47
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|December 22, 1999
[Continuing medical education (CME) in neurology. Concept of the German Society of Neurology (DGN) and the Neurology Section of the Professional League of German Neurologic Medicine (BVDN)]P Reuther, H C Diener, P Franz, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 15, 2001
Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trialK R Lees, J F Lavelle, L Cunha, et al.
Cephalalgia : an International Journal of Headache|September 5, 2001
The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trialH C Diener, P Tfelt-Hansen, F de Beukelaar, et al.
International Angiology : a Journal of the International Union of Angiology|July 18, 2012
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysisJ Harenberg, S Marx, H-C Diener, et al.
Neurology|November 9, 2005
Gray matter decrease in patients with chronic tension type headacheT Schmidt-Wilcke, E Leinisch, A Straube, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Neurology|March 17, 2012
Lateralized central facilitation of trigeminal nociception in cluster headacheD Holle, C Gaul, S Zillessen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 25, 2009
Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shuntC Weimar, D N Holle, J Benemann, et al.
Cephalalgia : an International Journal of Headache|October 1, 1996
Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study groupH C Diener, M Föh, C Iaccarino, et al.
Cephalalgia : an International Journal of Headache|September 3, 2009
Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraineS D Silberstein, J Schoenen, H Göbel, et al.
Pageof 47